Overview
Malignant melanoma of the finger is a rare but aggressive form of skin cancer that poses significant challenges due to its location and potential for rapid local invasion and metastasis. Unlike cutaneous melanomas on the trunk or extremities, finger melanomas often present with unique clinical features and require specialized management strategies. Early detection and accurate staging are crucial for determining the appropriate treatment approach, which may include surgical excision, reconstructive techniques, and adjuvant therapies. Given the rarity of this condition, clinical experience and evidence are often derived from case series and small cohort studies, as highlighted by the work of Song et al. [PMID:28601599].
Diagnosis
Diagnosing malignant melanoma of the finger involves a combination of clinical evaluation, imaging, and histopathological analysis. Patients typically present with changes in pigmentation, ulceration, or nodules on the fingertip or subungual region. Key clinical features include asymmetry, irregular borders, varying colors, and a diameter greater than 6 mm, although these may vary due to the anatomic constraints of the finger. Dermatoscopy can be particularly useful in evaluating these lesions, providing detailed images that aid in distinguishing melanoma from benign conditions such as traumatic pigmentation or chronic inflammation.
Imaging studies, including ultrasound and MRI, are often employed to assess the depth of invasion (Breslow thickness) and to evaluate for regional lymph node involvement or distant metastasis. Fine-needle aspiration biopsy (FNAB) or core needle biopsy may be necessary to obtain tissue for histopathological examination. Histologically, the diagnosis hinges on identifying atypical melanocytes with nuclear pleomorphism, increased mitotic activity, and evidence of invasion into the dermis or deeper structures. Immunohistochemical staining, particularly for S-100 protein and HMB-45, can further support the diagnosis by confirming melanocytic origin.
Management
Surgical Excision
The cornerstone of managing malignant melanoma of the finger is complete surgical excision with adequate margins. The extent of resection depends on the depth of invasion and clinical staging. For thin melanomas (Breslow thickness ≤ 1 mm), wide local excision with a margin of 1-2 cm may suffice. However, thicker lesions often require more extensive resections, potentially including partial finger amputation if necessary to achieve negative margins and prevent local recurrence.
Reconstructive Techniques
Reconstructive surgery following excision is critical to restore function and cosmesis. Free flap techniques, such as the dorsal radial artery perforator (DRAP) flap, have shown promising results in fingertip reconstructions. Song et al. [PMID:28601599] reported on a series of 20 cases where free DRAP flaps were successfully employed, achieving complete coverage without intra- or postoperative complications. This technique offers several advantages, including reliable vascular supply, preservation of sensation, and functional outcomes. Surgeons must carefully plan flap design to match the defect size and ensure adequate perfusion, often requiring microsurgical expertise.
#### Key Recommendations for Reconstruction
Adjuvant Therapies
Adjuvant therapies are considered based on the risk of recurrence and metastasis. High-risk features include deep invasion (Breslow thickness > 4 mm), ulceration, and lymphovascular invasion. Patients with high-risk melanomas may benefit from adjuvant radiation therapy, particularly for local control in cases where surgical margins are suboptimal. Systemic therapies, including immunotherapy with agents like ipilimumab or nivolumab, and targeted therapies such as BRAF inhibitors (vemurafenib, dabrafatinib) and MEK inhibitors (trametinib), are increasingly utilized, especially in advanced or metastatic settings. The decision to initiate adjuvant therapy should be individualized based on multidisciplinary tumor board discussions and patient-specific factors.
Complications
Despite the successful outcomes reported by Song et al. [PMID:28601599] in their series of 20 cases, potential complications following fingertip reconstruction must be carefully monitored. While their study highlighted the safety profile of free DRAP flaps with no reported intra- or postoperative complications, clinicians should remain vigilant for common reconstructive issues such as flap necrosis, hematoma formation, and infection. Sensory deficits, including altered two-point discrimination, are also critical to assess postoperatively, as these can significantly impact hand function and quality of life.
Monitoring and Management of Complications
Prognosis & Follow-up
The prognosis for malignant melanoma of the finger varies widely depending on the stage at diagnosis and the completeness of initial treatment. Early-stage melanomas (stages I and II) generally have better prognoses, with lower rates of recurrence and metastasis compared to advanced stages (III and IV). Song et al. [PMID:28601599] noted that in their cohort, follow-up over an average period of 12.8 months revealed static two-point discrimination averaging 5.5 mm, indicating satisfactory sensory outcomes post-surgery. However, long-term follow-up is essential to monitor for recurrence and metastasis.
Follow-Up Schedule
Key Prognostic Factors
By adhering to rigorous diagnostic protocols, meticulous surgical techniques, and comprehensive follow-up strategies, clinicians can optimize outcomes for patients with malignant melanoma of the finger, balancing functional recovery with oncologic safety.
References
1 Song D, Pafitanis G, Yang P, Narushima M, Li Z, Liu L et al.. Innervated dorsoradial perforator free flap: A reliable supermicrosurgery fingertip reconstruction technique. Journal of plastic, reconstructive & aesthetic surgery : JPRAS 2017. link
1 papers cited of 3 indexed.